Your browser does not support JavaScript!

Investment product trends: are further changes needed to contribute to the RIS and CMU (ETFs, ELTIFs, AIFs…) ?

Day 2 Afternoon

Thursday 14 September

Room :



Thorsten Pötzsch
Chief Executive Director of Securities Supervision/Asset Management - Federal Financial Supervisory Authority, Germany (BaFin)
Public Authorities
Annemie Rombouts
Deputy Chair - Financial Services and Markets Authority, Belgium (FSMA)
Marco Zwick
Director - Commission de Surveillance du Secteur Financier (CSSF)
Industry Representatives
Matteo Andreetto
Head of Global Advisors’ SPDR/ETF Business - State Street Global Advisors
Christoph Bergweiler
Chair of the Board of JPMorgan Asset Management (Europe) S.àr.l. - J.P. Morgan Asset Management (Europe) S.à r.l., Frankfurt Branch
Stéphane Janin
Head of Global Regulatory Developments and Public Affairs - AXA Investment Managers
Other stakeholder & expert
Gerben Everts
Executive Director - European Investors' Association


The first part of this session will focus on assessing current trends in the retail investment product market, whether retail investment needs are appropriately served by the existing product frameworks (e.g. UCITS, AIFMD, ELTIF) and whether the product-related proposals of the Retail Investment Package (RIP) are expected to have a positive impact on these trends.

The panel will also assess whether any further improvements are needed in the EU investment product frameworks to foster greater engagement of retail investors in capital markets and whether more needs to be done at the product level in the RIP and CMU initiatives. In terms of scope, the discussion will focus mainly on investment funds.

Points of discussion

  1. What are the current trends in the European retail investment product market? What are the key issues e.g. in terms of fragmentation, size of funds…? Do the current investment product categories and corresponding frameworks cover the main needs of retail investors? What enhancements are expected for retail investors from the changes adopted in the context of the AIFMD and ELTIF reviews?